Stanford launches Project Baseline study by enrolling first participant

Stanford began enrolling the first participants in the Project Baseline study - a massive enterprise whose goal is to map the many factors that influence human health. The project - a joint effort of Stanford Medicine, Duke University School of Medicine, Verily and Google - plans to enroll some 10,000 participants over the next few years.

CANVAS Program Results Presented at American Diabetes Association Meeting

The results of the CANVAS Program, in which Stanford Department of Medicine faculty played several leading roles, were presented on June 12, 2017, during the 77th annual meeting of the American Diabetes Association in San Diego.

The CANVAS Program (CANagliflozin CardioVascular Assessment Study) investigated canagliflozin, a drug for patients with type 2 diabetes who were at high risk of cardiovascular events, in over 10,000 participants who were followed over an average of three years.  The study showed that canagliflozin significantly reduced cardiovascular death, nonfatal myocardial infarction or nonfatal stroke by 14% compared with placebo. Canagiflozin increased the risk of amputation – usually at the level of toe or metatarsal.  

Stanford-AstraZeneca Collaboration Funds Two New Projects

The Stanford Center for Clinical Research (SCCR), led by Kenneth Mahaffey, MD (professor of cardiovascular medicine), and AstraZeneca are pleased to announce that they have entered into the second year of their collaboration. The collaboration focuses on cardio-metabolic and respiratory diseases, oncology, mobile health (mHealth), innovations in clinical trial design and operations, big data and novel data analytics approaches, and innovative education and training initiatives.  Two million dollars in funding has been provided to support six innovative research projects by Stanford investigators over the three-year collaboration. The collaboration provides up to $260,000 to each project for its one-year duration.

Software will help researchers manage, track clinical research

Stanford is implementing a universitywide system for managing clinical research to make it easier for researchers to track studies, monitor participant recruitment and manage and share data.

The system is based on OnCore Enterprise Research software from Forte Research Systems, and its deployment is being overseen by Spectrum (the Stanford Center for Clinical and Translational Research and Education) and the Stanford Center for Clinical Research in the Department of Medicine. The Stanford Cancer Institute has used this system since 2005, and its technical team will be assisting Spectrum and SCCR in the launch.


Jun June 10 Wed 2015

Research Corner with Ken Mahaffey and Glenn Chertow

This is a video that is party of a series led by Dr. Ken Mahaffey, Vice-Chair for Research in the Department of Medicine at Stanford University. 

In this interview, Dr. Mahaffey interviews Dr. Glenn Chertow, Chief for the Division of Nephrology to discuss a the research going on in his division, including highlights from early career faculty.

Apr April 01 Wed 2015

Research Corner with Ken Mahaffey and David Maron

This is a video that is party of a series led by Dr. Ken Mahaffey, Vice-Chair for Research in the Department of Medicine at Stanford University. 

In this interview, Dr. Mahaffey sits down with Dr. David Maron, Director for Stanford Preventive Cardiology to discuss a number of research programs that his group is involved in.

Jun June 17 Tue 2014

Research Corner with Ken Mahaffey and Harry Greenberg

Our Vice Chair for Clinical Research, Dr. Kenneth Mahaffrey interviews Dr. Harry Greenberg. Dr. Greenberg is the Senior Associate Dean in the School of Medicine. This is a first in a series of videos looking into the research being done with Stanford's Department of Medicine.